argyrotsipi/train-dataset huggingface dataset:
Creative Industries — House of Commons, 2016-07-07
Topic: Culture
Edward Vaizey (Conservative, Centre-right): I thank the hon. Gentleman for his kind words. He has allowed me to make a further point about the culture White Paper, in which we announced our proposed Great Place scheme. We have seen the huge success of Liverpool’s designation as European capital of culture, and the huge success of the city of culture scheme, initiated by the last Labour Government, which first benefited Derry/Londonderry and will benefit Hull next year. The Great Place scheme is designed to allow local authorities a small amount of funding to create a cultural strategy. The North East Culture Partnership was one of the inspirations for the idea. In the NECP, 12 councils and five universities have come together to create a coherent vision for culture in the north-east. It is important to note that it is a long-term vision, covering not just the next 12 months but the next 15 years I agree with the hon. Member for Glasgow North that we should encourage councils to understand the importance of culture in shaping places, creating jobs and bringing communities together, but also in improving health and wellbeing and contributing to education.
Creative Industries — House of Commons, 2016-07-07
Topic: Culture
Edward Vaizey (Conservative, Centre-right): I do not want to range too far from my brief and start commenting on local authority funding, but, in my view, that is possible. I object to the fact that culture is always at the back of the queue, and that when it comes to making savings, it is the first thing that some councils look at. However, many imaginative councils—Labour and Conservative, and possibly even SNP—have shown that it is possible to continue to fund culture, and to embed it in many different areas rather than simply putting it in a silo labelled "culture" I think that I have covered quite a lot of ground in a slightly bitty way. I have not really put together the narrative that I hoped to put together, partly because I was slightly discombobulated by the pithiness of the remarks of the hon. Member for Luton North, but let me say this. I think that we in the United Kingdom are incredibly lucky to have such extraordinary cultural and creative industries, driven by some remarkable people. They have been supported strongly by Government, particularly through tax reliefs, and also in focusing on skills and a wider strategy We must make sure that in a Brexit world we work with the arts and creative industries, which are the calling cards of this fantastic country. We must ensure that they are part of the debate. We must ensure that, as the hon. Member for Bristol East (Kerry McCarthy) said, they have a voice in a practical way. I can tell her that I came here from a meeting this morning of the inter-ministerial group, where we discussed DCMS-relevant sectors, looking at key business areas across Government. Tourism, the creative industries, the media, and arts and culture were all part of that debate. We have already seconded one very senior civil servant to the Brexit unit. We will make sure, in a practical way, that culture and the creative industries are taken account of, but also, in a more wide-ranging way, that the voices of our artists and creators are heard as we forge a new way forward for the United Kingdom.
NHS Bursary — House of Commons, 2016-05-10
Topic: Health
Questions: What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.; What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.; What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.
Benedict Gummer (Conservative, Centre-right): The reform to the NHS bursary will lift the cap currently placed on university places for nurses, midwives and allied health professions. Universities will be able to train up to 10,000 extra students by the end of this Parliament. This increase in UK graduates will reduce NHS reliance on expensive agency staff and staff from overseas.
NHS Bursary — House of Commons, 2016-05-10
Topic: Health
Questions: What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.; What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.; What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.
Benedict Gummer (Conservative, Centre-right): I would like to congratulate my friend the leader of the Scottish Conservative party, who has led the extraordinary resurgence of Conservatism and Unionism north of the border I regret very much that the SNP is not endorsing our plan to give opportunity to thousands more people who want to become nurses, especially those from under-privileged backgrounds. We will of course monitor the reform, not only as we continue our process towards making a decision, taking account of all the equalities analysis that will be done in the interim, but after the final decision has been made.
NHS Bursary — House of Commons, 2016-05-10
Topic: Health
Questions: What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.; What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.; What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.
Benedict Gummer (Conservative, Centre-right): The NHS benefits enormously from mature students entering the service, and that is why we have already said that we will be looking at offering second-degree bursaries in the scheme. The consultation is clear: it asks a number of open questions, inviting responses from nurses and nurse trainees about how best to support mature students. We will be looking at those carefully as we formulate our conclusions.
NHS Bursary — House of Commons, 2016-05-10
Topic: Health
Questions: What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.; What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.; What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.
Benedict Gummer (Conservative, Centre-right): South of the border we have been able over the past six years to increase the number of nurses, both in training and in the service, which has been made possible by the stronger economy and the stewardship of the NHS, in such contrast to the developing picture in Scotland. We are able to expand the numbers in training by up to 10,000 between now and 2020 as a result of that innovative policy, and that is why it should also be adopted in Scotland.
NHS Bursary — House of Commons, 2016-05-10
Topic: Health
Questions: What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.; What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.; What assessment he has made of the potential effect of his proposals to reform the NHS bursary on future levels of recruitment into the medical professions.
Benedict Gummer (Conservative, Centre-right): It depends of course on the career progression of that particular nurse, but the repayment terms will be precisely those for students of other degrees. Newly qualified nurses will not pay any more than they do currently, and the exact rates at which they will pay back—9% above £21,000—are outlined carefully in the consultation document. I recommend that the hon. Lady looks at it and sees the benefits that will come from the reform that, were it to be adopted in Scotland, would provide an enormous benefit to the service north of the border.
Specialist Nurses: Disabled People — House of Commons, 2016-05-10
Topic: Health
Benedict Gummer (Conservative, Centre-right): Specialist nurses make a valuable contribution to the care of disabled people. They have specialist post-registration qualifications, which are attained through additional training. There are now 3,000 more nurses working in the NHS than in May 2010, ensuring that disabled people continue to receive the highest possible quality care.
Specialist Nurses: Disabled People — House of Commons, 2016-05-10
Topic: Health
Benedict Gummer (Conservative, Centre-right): It is true that the skills mix and the way in which specialist nurses have changed over the past six years may well account for the variation that the hon. Lady has noticed—I am willing to write to her with the detail—but the total number of nurses has increased, and we are giving better and more varied training to nurses across the board so that they can deal with the specialist problems that are increasingly the core part of their work.
Specialist Nurses: Disabled People — House of Commons, 2016-05-10
Topic: Health
Benedict Gummer (Conservative, Centre-right): Funding for nurses has increased over the past six years. It is because of the sixth largest increase in the NHS budget that we can guarantee that nursing numbers will remain in that strong position for the remainder of this Parliament. That will include specialist nurses. My role is to make sure that as many nurses as possible get additional training so that we have a wider and richer skills mix, specifically so that nurses can develop their careers—something that I am afraid was often made more difficult rather than easier under the previous career structure.
Biosimilar Medicines — House of Commons, 2016-05-10
Topic: Health
George William Freeman (Conservative, Centre-right): The biosimilars—the generic versions of biologic products—represent part of the extraordinary range of new drugs that are becoming available for the benefit of our patients. The Government are committed to ensuring access to drugs for UK patients at the highest level of quality and safety, and to ensuring that effective biosimilar medicines are available. That is why we are leading, not just here but in Europe, the regulatory regime through the Medicines and Healthcare Products Regulatory Agency as the lead assessor and rapporteur. In the NHS, the chief pharmaceutical officer, Keith Ridge, and the commercial medicines unit in my directorate have put together a framework agreement for biosimilars, and through the medicines optimisation programme we are looking specifically at biosimilars, and we have set up a national biosimilars medicines group.
Biosimilar Medicines — House of Commons, 2016-05-10
Topic: Health
Tania Mathias (Conservative, Centre-right): I thank my hon. Friend for that answer. May I ask also that where NHS pharmacists are involved in oncology clinics, there is a higher prescribing of biosimilars? What steps are in place to encourage more oncology clinics to involve NHS pharmacists at the start of the patient’s treatment journey?
Biosimilar Medicines — House of Commons, 2016-05-10
Topic: Health
George William Freeman (Conservative, Centre-right): Not surprisingly, my hon. and, in this field, learned Friend makes a very important point. We have set up a number of initiatives to that very end: to make sure that our pharmacologists and pharmacists in the system are alert and have all the information they need to increase the prescription of biologics and the generic versions, biosimilars. I will happily write to her, describing a range of initiatives that are in place which we are pursuing to that end.
Biosimilar Medicines — House of Commons, 2016-05-10
Topic: Health
Christopher Laurie Malthouse (Conservative, Centre-right): One of the issues around the adoption of biosimilars and, indeed, driving down the NHS drugs budget generally is the lack of local analysis of patterns of prescribing against efficacy and cost. I wonder whether the Minister would consider encouraging clinical commissioning groups to appoint analytical pharmacists, who could look at this equation and recommend different prescribing decisions on a local basis.
Biosimilar Medicines — House of Commons, 2016-05-10
Topic: Health
George William Freeman (Conservative, Centre-right): My hon. Friend makes a really interesting point. It goes to the heart of the work that we are doing at the moment with CCGs, in terms of use of data to map and track prescribing practice across the system. I will happily pick up the point about ensuring that biosimilars are incorporated in that.
Lyme Disease — House of Commons, 2016-05-10
Topic: Health
Jane Ellison (Conservative, Centre-right): Lyme disease is a complex infection, so we recognise that there are real challenges in diagnosis and treatment. In the light of this, I am pleased to say that the Department plans to commission three reviews on the diagnosis, treatment and transmission of Lyme disease to inform future decision making.
Lyme Disease — House of Commons, 2016-05-10
Topic: Health
Andrew George Stephenson (Conservative, Centre-right): A constituent in Earby was struck down with a debilitating illness several years ago, which has totally destroyed her quality of life. Since then, I have been visiting her regularly at home every few months, as she has fought to get a diagnosis. Over recent months, all the evidence has started to point towards Lyme disease, but there seems to be precious little support out there for people with this condition. What more can my hon. Friend do to support constituents like mine?
Lyme Disease — House of Commons, 2016-05-10
Topic: Health
Jane Ellison (Conservative, Centre-right): In addition to the reviews that the chief scientific adviser is overseeing, we have commissioned the National Institute for Health and Care Excellence to develop a new evidence-based guideline for care, specifically to respond to the sort of situation that my hon. Friend describes with his constituent. That is for publication in 2018 and it is being prioritised because of the interest in this area.
Agency Staffing Expenditure — House of Commons, 2016-05-10
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): We have taken tough measures to control unsustainable spending on agency staff, which cost the NHS more than £3 billion last year. Overall agency spend is now falling and we expect to save the NHS at least £1 billion this year as a result.
Agency Staffing Expenditure — House of Commons, 2016-05-10
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): I think the hon. Gentleman is right that we have historically not trained enough staff to work in the NHS and been over-optimistic about the staff needs. That is why, in this Parliament, we will be training over 11,000 more doctors as a result of the spending review, and 40,000 more nurses.
Agency Staffing Expenditure — House of Commons, 2016-05-10
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): Perhaps I can give the hon. Lady some comfort. I recognise that there is a big mountain to move, but the changes we made last year were not just about changing the rates paid to agencies. They were also about capping the amounts agencies can pay their own staff, because we think it is incredibly divisive inside hospitals to have two nurses doing exactly the same work, but one being paid dramatically more than the other. We are also capping the total amount hospitals can spend on agency staff. The result is that the monthly spend on agency staff is now falling and we are on track to reduce the agency bill by about £1 billion in this Parliament.
Agency Staffing Expenditure — House of Commons, 2016-05-10
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): May I start by thanking the hon. Member for Ellesmere Port and Neston (Justin Madders) for his generous congratulations earlier, and indeed for making history himself by being the first Opposition Member I can remember to congratulate the Government on hitting a target I say to the hon. Lady that, as a result of the measures we have taken to deal with the agency staff issue, we think we have saved £290 million compared with what we would have spent since last October, two thirds of trusts are reporting savings and the price paid for agency nurses is 10% lower than it was in October. The root cause of the problem is, as the hon. Member for Southport (John Pugh) said, our failure in the past to recruit enough staff. One of the reasons for that is that successive Governments failed to understand the needs of nursing in wards, which is why we had the problem at Mid Staffs. Because we are addressing that, we are now able to make sure that we do not pay excessive rates for agency staff.
Agency Staffing Expenditure — House of Commons, 2016-05-10
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): I thank the hon. Lady for her reasonable tone and absolutely give her that assurance. We have always wanted a negotiated outcome to this dispute. That is why we paused the introduction of the new contracts last November to give talks a chance to succeed, and it is why this week I have said we will further pause the introduction of the new contracts to see whether we can get a negotiated outcome. We want a motivated workforce and we are highly cognisant of the fact that hospitals that offer seven-day care and higher standards of care for patients are the very hospitals that have some of the highest levels of morale in the NHS. It takes two to tango, and I very much hope that the British Medical Association will play ball and its part this week in helping us to deliver a safer seven-day NHS.
Rarer Cancers — House of Commons, 2016-05-10
Topic: Health
George William Freeman (Conservative, Centre-right): The extraordinary pace of progress in biomedical science, not least in genomics and data, is transforming our understanding of cancer. It is leading to greater identification of more rare cancers, and indeed to more diseases becoming rare diseases. That is why we have invested so heavily in Genomics England and set up the 13 genomic medicine centres around the UK, leading in cancer and rare disease diagnosis. I am delighted that we are now setting up a Northern Ireland General Medical Council, which will collect 17,000 samples. We will implement the recommendations of the independent cancer taskforce on diagnosis and we are setting up a series of regional genetic laboratories and infrastructure. I believe the hon. Gentleman will be able to see that we are investing heavily in making sure we lead not only in the science but in the adoption of genomic medicine in the NHS.
Rarer Cancers — House of Commons, 2016-05-10
Topic: Health
George William Freeman (Conservative, Centre-right): The hon. Gentleman makes an important point. In both Northern Ireland and the Republic, I have seen some great leadership in this field, and as the UK Parliamentary Under-Secretary of State for Life Sciences, I would be delighted to pick this up through that council, and suggest that our nations, working together, can collaborate better, not least in implementing the accelerated access reforms that I am putting in place. Those reforms, aligned with the cancer drugs fund in its revised format, should see us able to accelerate the adoption of drugs for rarer cancers for patients’ benefit.
Rarer Cancers — House of Commons, 2016-05-10
Topic: Health
John Charles Baron (Conservative, Centre-right): In part because they are the hidden majority, people with rarer cancers are often diagnosed later, often through an emergency presentation. That can make for more aggressive treatments, which can have a longer-term impact on health. Will the Minister update the House on tailored recovery packages, and the plan to roll those out that was outlined by the Government back in September last year—a Government who have, I must say, been a great friend to the cancer community?
Rarer Cancers — House of Commons, 2016-05-10
Topic: Health
George William Freeman (Conservative, Centre-right): I am very grateful for that acknowledgment. We have put £1 billion into the cancer drugs fund, and we are completely committed to increasing the pace at which we bring cancer drugs through. It is true that cancer outcomes have improved quickly since 2010; in 2014-15, over 645,000 more patients with suspected cancers were seen. That is an increase of 71%. Almost 40,000 more patients were treated for cancer—an increase of 17%. We have announced funding of up to £300 million a year by 2020 to increase diagnostic capacity, so that we can meet the new target, which is that patients will be given a definitive cancer diagnosis or the all-clear within 28 days of being referred by a GP.
Rarer Cancers — House of Commons, 2016-05-10
Topic: Health
George William Freeman (Conservative, Centre-right): I will happily look at that as part of the discussions with the council that I just touched on. We are determined to make sure that this life science revolution is not just in the Oxford-Cambridge-London triangle, but goes out across all the devolved areas, which of course are leading on much of the science. That is why we are committed, through the National Institute for Health Research and the NHS, to creating hubs across the country, so that everybody can benefit.
Rarer Cancers — House of Commons, 2016-05-10
Topic: Health
David Arthur Stephen Tredinnick (Conservative, Centre-right): Is my hon. Friend aware that about a third of people, including those with rare cancers, will, on their cancer journey, use some form of complementary or alternative medicine? Is he further aware that there is a range of new treatments out there that are being used in the private sector, including virotherapy and hyperbaric oxygen therapy? The second particularly can help people who have serious effects from chemotherapy and radiotherapy. Will he look at some of these treatments and write to me about them?
Rarer Cancers — House of Commons, 2016-05-10
Topic: Health
George William Freeman (Conservative, Centre-right): I am not against people taking whatever they feel helps, but my hon. Friend will understand that in this field, in allocating every pound, we need to be guided by the very best science and evidence. Internationally, we are applauded for the quality of our assessment, and I intend to do everything to make sure that that continues.
Rarer Cancers — House of Commons, 2016-05-10
Topic: Health
Andrew William Murrison (Conservative, Centre-right): Outcomes in cancer are not just about survival. Does the Minister agree that nowhere is the case for a seven-day NHS stronger than in palliative medicine, and will he say what can be done, in rolling out the 7/7 NHS, to address the scandal whereby only one in five hospitals has specialist palliative care cover on a Saturday and Sunday?
Rarer Cancers — House of Commons, 2016-05-10
Topic: Health
George William Freeman (Conservative, Centre-right): My hon. Friend makes a really important and specific point. He is absolutely right, and that is one reason why we are committed to our seven-day NHS. It is improving—I can share the data with him—but he makes a good point, and that is one reason why we need to continue.